4//SEC Filing
Garcia-Parada Carlos 4
Accession 0001140361-22-005831
CIK 0001281895other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 9:32 PM ET
Size
16.5 KB
Accession
0001140361-22-005831
Insider Transaction Report
Form 4
Garcia-Parada Carlos
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-14+54,006→ 54,006 totalExercise: $20.00Exp: 2032-02-13→ Common Stock (54,006 underlying) - Award
Restricted Stock Units
2022-02-14+17,322→ 17,322 total→ Common Stock (17,322 underlying)
Footnotes (3)
- [F1]This option represents a right to purchase a total of 54,006 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001839342
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 9:32 PM ET
- Size
- 16.5 KB